Skip to main content

Table 10 Outcomes predicted by models for one birth cohort in Eur-region

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

 

POLYMODa

Roxanne

CoRoVa

Undiscounted cases

   

   Mild

22,708

32,186

28,680

   Moderate

10,360

14,580

10,430

   Severe

1,658

2,324

1,806

   Nosocomial

415

528

452

   Deaths

1

1

1

   GP-visits

12,019

14,580

10,430

   Inpatient (comm. acq.)

1,658

2,324

1,860

Discounted savings

   

   Outpatient

€480,745

€556,984

€829,111

   Inpatient

€4,643,286

€5,949,119

€4,714,920

   Indirect

€ 1,322,021

€ 2,111,857

€ 2,088,993

Discounted net costs b

€ 9,032,932

€ 9,842,807

€ 9,518,208

Discounted QALYs

   

   Mortality

25

27

26

   Morbidity

131

166

142

  1. a. Approximations for one cohort from the multi-cohort results; b. Health-care perspective.
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us